Fortress Biotech, Inc. (FBIO) › Operating Cash FlowFortress Biotech, Inc. (FBIO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$2.35M2010: -$5.68M2011: -$10.95M2012: -$23.19M2015: -$20.38M2016: -$45.81M2017: -$81.31M2018: -$98.85M2019: -$94.96M2020: -$83.68M2021: -$116.54M2022: -$179.40M2023: -$128.22M2024: -$80.19M2025: -$65.78M-$65.78M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$65.78M+18.0%2024-$80.19M+37.5%2023-$128.22M+28.5%2022-$179.40M-53.9%2021-$116.54M-39.3%2020-$83.68M+11.9%2019-$94.96M+3.9%2018-$98.85M-21.6%2017-$81.31M-77.5%2016-$45.81M-124.8%2015-$20.38M—2012-$23.19M-111.8%2011-$10.95M-92.9%2010-$5.68M-141.5%2009-$2.35M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share